what are the different glp-1 drugs How medications transforming diabetes and weight loss treatment GLP-1 Receptor Agonists | New
Description
Injectables: GLP-1 and GIP/GLP-1 RAs versus basal insulin Randomised controlled trials (RTCs) have demonstrated that both semaglutide (Aroda et al, 2017) and tirzepatide (Ludvik et al, 2021
The primary outcomes of these trials were 3-point major adverse cardiovascular event (3-MACE) and the studies have together provided a wealth of data that, amongst others, have changed clinical guidelines
Louis College of Pharmacy Shared Faculty/Clinical Pharmacist Walgreens Pharmacy Roxane L
Gradually increasing dosage helps avoid sudden adverse effects from drug doses [16]
